• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

120.10 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 197
Open 120.10
Bid (Size) 115.00 (1,400)
Ask (Size) 121.38 (200)
Prev. Close 120.10
Today's Range 120.10 - 120.10
52wk Range 109.66 - 175.77
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
March 27, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid
March 24, 2026
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ... 
Via StockStory

Performance

YTD
-26.9%
-26.9%
1 Month
+5.2%
+5.2%
3 Month
-28.7%
-28.7%
6 Month
-19.2%
-19.2%
1 Year
-5.6%
-5.6%

More News

Read More
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
March 19, 2026
Via StockStory
Repligen Corp (NASDAQ:RGEN) Stock Falls Despite Q4 Earnings Beat as 2026 Guidance Disappoints ↗
February 24, 2026
Via Chartmill
Topics Earnings
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
March 15, 2026
Via StockStory
News headline image
2 Growth Stocks Set to Flourishand 1 We Turn Down
March 13, 2026
Via StockStory
News headline image
3 Profitable Stocks We Keep Off Our Radar
March 10, 2026
Via StockStory
Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million ↗
March 06, 2026
Via The Motley Fool
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
March 06, 2026
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We’re Skeptical Of
March 02, 2026
Via StockStory
News headline image
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
March 02, 2026
Via StockStory
Topics Stocks Supply Chain
News headline image
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know
February 27, 2026
Via StockStory
Topics Economy Stocks
News headline image
Repligen (RGEN) Q4 2025 Earnings Call Transcript ↗
February 24, 2026
Via The Motley Fool
Topics Earnings World Trade
News headline image
Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations
February 24, 2026
Via StockStory
News headline image
Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect
February 22, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 We Avoid
February 19, 2026
Via StockStory
News headline image
3 Volatile Stocks Walking a Fine Line
February 02, 2026
Via StockStory
News headline image
2 Cash-Producing Stocks to Target This Week and 1 We Ignore
January 28, 2026
Via StockStory
News headline image
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
January 26, 2026
Via StockStory
Topics Stocks
News headline image
3 High-Flying Stocks That Fall Short
January 18, 2026
Via StockStory
News headline image
Why Repligen (RGEN) Shares Are Sliding Today
January 14, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges
January 05, 2026
Via StockStory
News headline image
1 Volatile Stock to Target This Week and 2 We Turn Down
December 07, 2025
Via StockStory
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
November 21, 2025
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
November 11, 2025
Via StockStory
Topics Artificial Intelligence Stocks

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 120.10
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 04/10/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 6.69B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap